No purchaser interested in Jugoremedija – Second attempt at sale of Zrenjanin pharmaceutical company falls through
Illustration (Photo: Grycaj/shutterstock.com)
– I will officially pronounce the sale unsuccessful on Monday, August 6. It remains for me to agree with the board of creditors on the further steps, as well as the manner of monetizing the property of the bankruptcy debtor, so that the creditors’ claims would be settled – confirmed the bankruptcy supervisor, Radovan Savic.
After the Commercial Court of Zrenjanin stopped the sale of the ruined company last autumn, having estimated that it was premature, the first ad, placed last summer, proved unsuccessful, as there had been no interested purchasers. The ad was repeated with unchanged terms. Jugoremedija was offered as a legal entity, with its property estimated at nearly RSD 3.9 billion.
In addition to the real estate, the equipment and the machinery, the property on offer contains a lawsuit for the recovery of the permits for the marketing of 22 products against Novi Sad’s Union Medic. These include nine trademarked medical products and 13 generic ones, for which Jugoremedija owns the entire technological procedure. They were acquired by the Novi Sad-based company while it was renting the facility in Zrenjanin. The company now refuses to give back the permits.
– The permits are this factory’s most valuable piece of property and no one needs Jugoremedija without them. We have been emphasizing this since we started looking for an owner of this sole remaining non-privatized Serbian pharmaceutical company – Vladimir Pecikoza, the president of the board of creditors, told Novosti.
He says that the board will fight the devaluation of Jugoremedija with all its might. They also expect the state, which owns 47% of the factory’s capital, to take a more active role in this.
Tags:
sale of Jugoremedija
privatization of Jugoremedija
production of medical drugs
production of medicaments
production licenses of Jugoremedija
medicines
medicaments
medicine factory
production of pharmaceutical products
permit for marketing of medicines
Radovan Savic
Vladimir Pecikoza
Comments
Your comment
Most Important News
Full information is available only to commercial users-subscribers and it is necessary to log in.
Pratite na našem portalu vesti, tendere, investicione projekte, grantove i pravnu regulativu.
Registracija na eKapiji vam omogućava pristup potpunim informacijama i dnevnom biltenu
Naš dnevni ekonomski bilten će stizati na vašu mejl adresu krajem svakog radnog dana. Bilteni su personalizovani prema interesovanjima svakog korisnika zasebno,
uz konsultacije sa našim ekspertima.

Izdanje Srbija
Serbische Ausgabe
Izdanje BiH
Izdanje Crna Gora